Viewing Study NCT06998056


Ignite Creation Date: 2025-12-24 @ 11:37 PM
Ignite Modification Date: 2025-12-26 @ 11:11 PM
Study NCT ID: NCT06998056
Status: COMPLETED
Last Update Posted: 2025-12-10
First Post: 2025-05-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety Study of Roflumilast Cream 0.05% in Infants Aged 3 Months to Less Than 2 Years With Atopic Dermatitis
Sponsor: Arcutis Biotherapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module